Alan H Friedman, MD Email Alan Friedman
- CLINICAL PROFESSOR | Ophthalmology
- CLINICAL PROFESSOR | Pathology, Molecular and Cell Based Medicine
- Ophthalmology (Eye)
- Ophthalmic Pathology
- Hospital Affiliations
- The Mount Sinai Hospital
- New York Eye and Ear Infirmary of Mount Sinai
Alan H. Friedman, M.D., is Clinical Professor of Ophthalmology and Pathology at The Icahn School of Medicine at Mount Sinai. He received his undergraduate degree from Cornell University, BA with Honors in Chemistry, and his M.D. from New York University School of Medicine. He did an Internship in Straight Medicine at Bellevue Hospital in New York and then served for two years as a captain in the United States Army Medical Corps. Following military service he trained in Ophthalmology at New York University Medical Center followed a Fellowship in Ophthalmic Pathology at New York University. Following this phase of training he served as Assistant and then Associate Professor of Ophthalmology and Pathology at Albert Einstein College of Medicine/ Montefiore Hospital and Medical Center. During this time, he spent a year at The Royal Postgraduate Medical School at Hammersmith Hospital in London, England studying under Professor A.G.E Pearse. He was appointed Clinical Professor of Ophthalmology and Pathology at The Mount Sinai Medical Center in 1977.
He has given The Herman Krieger Goldberg Lecture, The Robert S. Coles Memorial Lecture at the New York Academy of Medicine and the Lorenz E. Zimmerman Lecture at the annual meeting of the American Academy of Ophthalmology in New Orleans in November, 2007. He has been Visiting Professor of Ophthalmology at Wills Eye Hospital, Tufts-New England Medical Center and The University of Pittsburgh. He was Guest-of Honor at The Pan-Hellenic Ophthalmology Society Annual Meeting, The Italian Ophthalmology Society Annual Meeting and The European Ophthalmic Pathology Society. He has lectured widely in New York City and elsewhere. He is a member of The American Ophthalmological Society, The Verhoeff-Zimmerman Society (President, 2006), The Eastern Ophthalmic Pathology Society (President, 1997), The American Association of Ophthalmic Pathologists (President 1992-1994), The American Uveitis Society, The International Uveitis Study Group, The American Academy of Ophthalmology (Honor and Senior Honor Awards), The New York Ophthalmological Society and The Manhattan Ophthalmological Society. He is a Fellow of The Royal College of Ophthalmologists.
He is author or co-author of over 200 articles and textbooks. He was co-author of Congenital Fundus Lesions (with Juan Orellana, M.D.), Diagnosis and Management of Uveitis (with Maurice Luntz, M.D., and Walter Henley, M.D.) and was co-author and editor of Intraocular Tumors and Uveitis (The American Academy of Ophthalmology 1978-1988). He has held grants from the National Eye Institute (as co-investigator) and was a participant in The Studies of Ocular Complications of AIDS.
BA with Honors, Cornell University
MD, NYU Medical Center
Internship, Internal Medicine
Bellevue Hospital Center
Fellowship, Ophthalmic Pathology
Bellevue Hospital Center
English, Spanish, German, French
The Zimmerman Lecture and Medal
The American Academy Of Ophthalmology
Roberts S. Coles Memorial Lecture
New York Academy of Medicine
The Ocular Complications of AIDS
Senior Honor Award
American Academy of Ophthalmology
Herman Krieger Goldberg Lecture
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Friedman did not report having any of the following types of financial relationships with industry during 2020 and/or 2021: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.